Last reviewed · How we verify
NCT06243718
Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.
trial in Diaphragmatic Paralysis in 45 participants. Currently enrolling.
10 October 2025
Quick facts
| Lead sponsor | Advanced Reconstructive Surgery Alliance |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 45 |
| Start date | 10 October 2023 |
| Primary completion | 10 October 2025 |
| Estimated completion | 10 October 2026 |
| Sites | 2 locations across United States |
Conditions studied
- Diaphragmatic Paralysis — all drugs for Diaphragmatic Paralysis →
- Pain, Chest — all drugs for Pain, Chest →
- Breath Shortness — all drugs for Breath Shortness →
Sponsor
Advanced Reconstructive Surgery Alliance
Who can join
Adults 18 to 70, any sex, with Diaphragmatic Paralysis or Pain, Chest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study utilizes a grounded theory methodology to explore patient experiences of phrenic nerve reconstructive surgery as a treatment for diaphragmatic paralysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06243718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diaphragmatic Paralysis
Currently open trials in the same condition.
- NCT06257589 — A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Pa · active not recruiting
Other Advanced Reconstructive Surgery Alliance trials
Trials by the same sponsor.
- NCT07012642 — Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema · EARLY_PHASE1 · recruiting
- NCT06257589 — A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Pa · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06243718 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Advanced Reconstructive Surgery Alliance
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06243718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing